 |
|
Potential early warning system for lung cancer identified
October 11, 2007Autoantibodies in lung cancer: possibilities for early detection and subsequent care
An immune system protein could act as an early warning system for lung cancer, reveals research published ahead of print in the journal Thorax.
Lung cancer kills around 900,000 people every year, and can take 20 years or more to develop fully. But it is usually only picked up at an advanced stage, when the chances of successful treatment are slim.
As yet, there is no effective early warning system to detect the disease in its early treatable stages, and the dismal long term prospects of patients with lung cancer have changed little in the past 30 years.
The research team analysed blood (plasma) samples from 50 healthy volunteers and 104 people with different types of lung cancer.
They tested for autoantibodies - immune system proteins directed at the body's own tissues in response to specific chemical signals in the body.
They looked in particular for a panel of seven autoantibodies, which are associated with 'solid tumours,' such a lung, breast, ovarian, and prostate cancers, and triggered when cancerous changes are taking place.
They found the presence of all seven autoantibodies, and very high levels of at least one of the seven in almost eight out of 10 samples taken from patients with confirmed lung cancer.
And these autoantibodies were found in eight out of the nine patients whose cancer had not infiltrated the lymph nodes, the body's gatekeepers.
This indicates that the disease had not yet spread elsewhere and offers an 80% chance of a cure.
Only one healthy volunteer had more than one of these autoantibodies in their blood.
Other research has indicated that these autoantibodies can be picked up as early as five years before clinical symptoms start to show.
In a previous study, the researchers found abnormally high levels of specific autoantibodies in patients with breast cancer, prompting them to suggest that a test for these could be added to the screening programme. That study also showed that these autoantibodies were present before clinical symptoms appeared..
The authors argue that the lungs are especially sensitive to radiation, so repeated chest x-rays are not ideal for picking up lung cancer.
A blood test, on the other hand, is cheap compared with imaging techniques, and has no side effects. And the panel can be changed to include more or different autoantibodies for lung and other cancers.
They suggest that the blood test could be used for people at increased risk of developing the disease, such as smokers and passive smokers.
If they test positive, these people could then be referred for more detailed scans, such as computed tomography (CT) or magnetic resonance imaging (MRI), they suggest.
BMJ-British Medical Journal
As yet, there is no effective early warning system to detect the disease in its early treatable stages, and the dismal long term prospects of patients with lung cancer have changed little in the past 30 years.
The research team analysed blood (plasma) samples from 50 healthy volunteers and 104 people with different types of lung cancer.
They tested for autoantibodies - immune system proteins directed at the body's own tissues in response to specific chemical signals in the body.
They looked in particular for a panel of seven autoantibodies, which are associated with 'solid tumours,' such a lung, breast, ovarian, and prostate cancers, and triggered when cancerous changes are taking place.
They found the presence of all seven autoantibodies, and very high levels of at least one of the seven in almost eight out of 10 samples taken from patients with confirmed lung cancer.
And these autoantibodies were found in eight out of the nine patients whose cancer had not infiltrated the lymph nodes, the body's gatekeepers.
This indicates that the disease had not yet spread elsewhere and offers an 80% chance of a cure.
Only one healthy volunteer had more than one of these autoantibodies in their blood.
Other research has indicated that these autoantibodies can be picked up as early as five years before clinical symptoms start to show.
In a previous study, the researchers found abnormally high levels of specific autoantibodies in patients with breast cancer, prompting them to suggest that a test for these could be added to the screening programme. That study also showed that these autoantibodies were present before clinical symptoms appeared..
The authors argue that the lungs are especially sensitive to radiation, so repeated chest x-rays are not ideal for picking up lung cancer.
A blood test, on the other hand, is cheap compared with imaging techniques, and has no side effects. And the panel can be changed to include more or different autoantibodies for lung and other cancers.
They suggest that the blood test could be used for people at increased risk of developing the disease, such as smokers and passive smokers.
If they test positive, these people could then be referred for more detailed scans, such as computed tomography (CT) or magnetic resonance imaging (MRI), they suggest.
BMJ-British Medical Journal
Autoantibodies Current Events and Autoantibodies News RSSSun exposure may trigger certain autoimmune diseases in women
Ultraviolet (UV) radiation from sunlight may be associated with the development of certain autoimmune diseases, particularly in women.
Scripps research scientists find key culprits in lupus
The more than 1.5 million Americans with systemic lupus erythematosus (or lupus) suffer from a variety of symptoms that flare and subside, often including painful or swollen joints, extreme fatigue, skin rashes, fever, and kidney problems.
Novel DNA vaccine leads to kidney damage prevention in systemic lupus erythematosus models
DNA vaccination using lupus autoantigens and interleukin-10 (IL-10, a cytokine that plays an important role in regulating the immune system) has potential as a novel therapy to induce antigen specific tolerance and may help to prevent kidney damage in patients with systemic lupus erythematosus (SLE).
'Autoantibodies' may be created in response to bacterial DNA
Autoimmune diseases have long been regarded as illnesses in which the immune system creates autoantibodies to attack the body itself.
Study reports success in treating a rare retinal disorder
Patients with a rare, blinding eye disease saw their vision improve after treatment with drugs to suppress their immune systems, according to researchers at the University of Michigan Kellogg Eye Center.
Study reports success in treating a rare retinal disorder
Patients with a rare, blinding eye disease saw their vision improve after treatment with drugs to suppress their immune systems.
Varicella zoster infection causes severe autoimmune hepatitis
Autoimmune hepatitis (AIH) is a chronic liver inflammation of unknown etiology that is characterized by the presence of circulatory autoantibodies and ongoing liver tissue damage.
New scientific knowledge on juvenile diabetes
Finnish scientists have reported a breakthrough in the attempts to understand the development of type 1 diabetes. They discovered disturbances in lipid and amino acid metabolism in children who later progressed to type 1 diabetes, also known as juvenile diabetes.
A reversal of thinking: How women with lupus can increase chance for healthy pregnancies
In the not so distant past, women with systemic lupus erythematosus (SLE), an autoimmune disease, were advised not to have children, and if they became pregnant, to have therapeutic abortions to prevent severe flares of their lupus.
Green tea may delay onset of type 1 diabetes
A powerful antioxidant in green tea may prevent or delay the onset of type 1 diabetes, Medical College of Georgia researchers say.
More Autoantibodies Current Events and Autoantibodies News Articles
 |
Autoantibodies, Second Edition by M.E. Gershwin (Editor), Pier-Luigi Meroni (Editor), Y. Shoenfeld (Editor) Autoimmune diseases are characterized by the occurrence of antibodies reacting with self constituents of the body. This exciting new reference is an exhaustive review of the main autoantibodies identified up to now, with particular emphasis on those autoantibodies that display a clinical value. Each chapter is focussed on a single family of autoantibodies by reviewing their historical notes, definition, origin and source(s) of the antigen(s) recognized, genetic associations, pathogenic mechanisms that are mediated, method(s) of detection and clinical utility (disease prevalence/association, diagnostic value, sensitivity and specificity, prognostic value). An ideal reference for anyone involved in the field of autoimmune diseases. * Incudes and... |
 |
Autoantibodies by J.B. Peter (Editor), Y. Shoenfeld (Editor) This volume is THE definitive, completely up-to-date, reference work for ALL researchers and clinicians working in autoimmunity. Up-to-Date: This is a timely critical review of more than 100 autoantibodies by leading experts in their respective fields, and includes many recent references. International Experts: The 120 Chapters have been written by the top international cadre of authors who have provided structured, expert contributions. Comprehensive: A total comprehensive perspective on the processes which induce, inhibit or otherwise affect autoantibodies in humans. Useful to Researchers and Clinicians: Chapters generally include methods of detection, pathogenic role, factors in pathogenicity and genetics as well as clinical utility with disease associations and... |
 |
Natural Autoantibodies: Their Physiological Role and Regulatory Significance by Yehuda Shoenfeld (Author), David A. Isenberg (Author) Natural Autoantibodies provides an in-depth analysis of all aspects of natural antibodies. The book examines the advantages and pitfalls of every type of technique that is widely used for detecting autoantibodies. It also covers the sequencing of human autoantibody genes, discussing how sequencing is undertaken and the genetic clues available to elucidate the genetic origins of autoimmunity. Animal models of autoimmunity are also covered, and the up-to-date account provided in this book explains how natural autoantibodies have important regulatory functions and also occasionally serve as templates for autoimmunity.Other topics examined in Natural Autoantibodies: Their Physiological Role and Regulatory Significance include idiotypes of natural autoantibodies; the pathogenic role of natural... |
 |
Autoantibodies and Autoimmunity: Molecular Mechanisms in Health and Disease by Kenneth Michael Pollard (Editor) This is the first book to address all aspects of the biology of autoantibodies in a single volume, including a discussion of immunology, experimental models, clinical aspects, and the use of autoantibodies as probes in molecular and cellular biology. The editor, currently professor at the W.M. Keck Autoimmune Disease Center of The Scripps Research Institute, has assembled an all-star team of authors to report on the latest research, technologies, and applications. Following an introductory chapter, the book goes on to cover such topics as cellular mechanisms of autoantibody production, clinical and diagnostic usefulness in human disease, and animal models used to study the elicitation of autoantibodies. The whole is rounded off with a look at future perspectives. With its... |
|
Diabetes risk and giving infants cereal early, late: autoantibodies to pancreatic islet cells.(Clinical Rounds): An article from: Pediatric News by Diana Mahoney (Author) This digital document is an article from Pediatric News, published by International Medical News Group on December 1, 2003. The length of the article is 1042 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Diabetes risk and giving infants cereal early, late: autoantibodies to pancreatic islet cells.(Clinical Rounds) Author: Diana Mahoney Publication: Pediatric News (Magazine/Journal) Date: December 1, 2003 Publisher: International Medical News Group Volume: 37 Issue: 12 Page: 32(2) Distributed by Thomson... | |
 |
Autoantibodies in Neurological Diseases (Topics in Neuroscience) by Angela Vincent (Editor), Gianvito Martino (Editor) John Radcliffe Hospital, Oxford, UK. Covers immunological and clinical aspects of immune-mediated diseases of the nervous system, with particular emphasis on disorders associated with autoantibodies. For researchers and clinicians. |
 |
Atlas of Immunofluorescent Autoantibodies by A.R. Krapf (Author), etc. (Author) |
![Increased sensitivity of autoantibody determination by coupled-particle light-scattering assay by poly(ethylene glycols)-modified beads [An article from: Analytica Chimica Acta]](http://ecx.images-amazon.com/images/I/415FBN4EPVL._SL160_.jpg) |
Increased sensitivity of autoantibody determination by coupled-particle light-scattering assay by poly(ethylene glycols)-modified beads [An article from: Analytica Chimica Acta] by C. Tozzi (Author), A. Salomone (Author), G. Giraudi (Author), L. Anfossi (Author), Bag (Author) This digital document is a journal article from Analytica Chimica Acta, published by Elsevier in 2004. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser. Description: New kinds of coatings by using polyethylene glycols were studied and were applied to a qualitative homogeneous immunoassay that exploits the agglutination reaction for the detection of autoimmune antibodies in a complex matrix. We used a piece of new technology, the Copalis^(TM), which uses a special optical-sizing flow particle analysis and a semiconductor laser as a light source. Polystyrene microbeads coated with the antigen were used as markers and were put in contact with the serum sample. Different... |
|
Clinical utility of autoantibodies directed against TSH-R.(TSH receptor)(TRAb): An article from: Medical Laboratory Observer by Roberto Rocchi (Author) This digital document is an article from Medical Laboratory Observer, published by Nelson Publishing on April 1, 2005. The length of the article is 4517 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Clinical utility of autoantibodies directed against TSH-R.(TSH receptor)(TRAb) Author: Roberto Rocchi Publication: Medical Laboratory Observer (Magazine/Journal) Date: April 1, 2005 Publisher: Nelson Publishing Volume: 37 Issue: 4 Page: 10(6) Distributed by Thomson... | |
 |
Autoantibodies: Webster's Facts and Phrases by Icon Group (Author) Ever need a fact or quotation on autoantibodies? Designed for speechwriters, journalists, writers, researchers, students, professors, teachers, historians, academics, scrapbookers, trivia buffs and word lovers, this is the largest book ever created for this single word. It represents a compilation from a variety of sources with a linguistic emphasis on anything relating to the term "autoantibodies," including non-conventional usage and alternative meanings which capture ambiguities. The entries cover all parts of speech (noun, verb, adverb or adjective usage) as well as use in modern slang, pop culture, social sciences (linguistics, history, geography, economics, sociology, political science), business, computer science, literature, law, medicine, psychology, mathematics, chemistry,... |
| © 2009 BrightSurf.com |